CN1199666C - Medicine 'Suyusan' for treating intractable ulcer - Google Patents
Medicine 'Suyusan' for treating intractable ulcer Download PDFInfo
- Publication number
- CN1199666C CN1199666C CNB011405104A CN01140510A CN1199666C CN 1199666 C CN1199666 C CN 1199666C CN B011405104 A CNB011405104 A CN B011405104A CN 01140510 A CN01140510 A CN 01140510A CN 1199666 C CN1199666 C CN 1199666C
- Authority
- CN
- China
- Prior art keywords
- powder
- powdery
- syngnathus
- present
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to medicine for quickly treating intractable ulcers, which is formed by uniformly mixing of bead layer powder, syngnathus powder, sodium borate, boneol, powdered notoginseng, phenytoin sodium, sodium benzoate and vitamin C according to specified amount. The present invention has the advantages of good curative effect, acceleration for wound healing and no toxic or side effect. The secondary reinfection of a wound surface can be effectively avoided, and the phenomena of medicine resistance and allergy can not be caused. The cure rate can reach 98.7% for intractable and chronic ulcers of the skin mucosa, and simultaneously, the present invention has strong operability and is convenient to popularize at all levels of medical institutions.
Description
Technical field
The present invention relates to a kind of surgical medicine product, particularly treat the powder of intractable ulcer.It is suitable for mucocutaneous intractable, chronic ulcerative treatment of diseases medicine, belongs to topical drug.
Background technology
Mucocutaneous intractable, chronic ulcer be clinical in common frequently-occurring disease.At present, often adopt antibiotic to infuse or oral to the treatment of this kind disease, in addition the Chang Gui therapy of changing dressings, promptly to the wound circumference skin degerming, normal saline cleans a wound, then with flap coverages such as vaseline oil sliver or gentamycin sliver, enclosing cover dressing, wrapping.Adopt the conventional therapy of changing dressings to play and protect wound as far as possible; avoid infecting again; the patient only relies on self-ability that wound is healed gradually; like this; owing to lack the essential condition of local nutritional labeling of wound and removing the necrotic tissue and promoting granulation; so wound healing is slower, causes the wound protracted course of disease sometimes, reaches several months, several years even decades.And adopt the antibiotic medicine treatment easily to cause drug resistance and anaphylaxis etc.
Summary of the invention
The object of the present invention is to provide a kind of powder for the treatment of intractable ulcer, it can overcome the deficiency of prior art, and multiple effects such as collection nutrition, sterilization, antibacterial, convergence, microcirculation improvement, help wound matrigel fibril and proteinic synthetic, the speed of accelerating wound healing can be impelled wound healing effectively.
The present invention measures pear powder layer, syngnathus and mud eel powder and process pulverizing, porphyrize, the Borax that sieves, Borneolum Syntheticum, Radix Notoginseng powder, sodium benzoate, phenytoin Sodium, vitamin C in accordance with regulations uniform mixing and forms.Its prescription is by mass percentage following:
Pear powder layer 18-50%; Syngnathus and mud eel powder 10-40%; Borax 2-15%; Borneolum Syntheticum 1-5%; Radix Notoginseng powder 1.3-9%; Sodium benzoate 0.02-0.3%; Phenytoin Sodium 5-30%; Vitamin C 0.5-5%.
Described pear powder layer is formed by southern pearl powder and Margarita layer powder uniform mixing, and they the two composition by weight ratio is 1: 4.
Described syngnathus and mud eel powder is formed by Endoconcha Sepiae, Os Draconis and Monopteri albi dry powder uniform mixing, and their threes' composition by weight ratio is 1: 1: 1.Wherein, Monopteri albi dry powder is from powder process, it by bright Monopteri albi through dry, porphyrize, sieving gets final product.All the other are all on sale on market.
Pear powder layer in this prescription is a composite powder, wherein contains 20 kinds of natural amino acids, natural activity calcium and ferrum, zinc, manganese, germanium, selenium and other trace elements, and utilization very easily is absorbed by the body.Antioxidant in its energy human activin, as superoxide dismutase, glutathion peroxidase etc., thus can stop the damage of radical pair cell membrane, and the various enzymatic activitys of energy human activin.Pear powder layer is nutrition, active substance, and it helps activating the metabolic activity of mucocutaneous cell and tissue, promotes tissue repairing ability, improves blood circulation, quickens collagen fiber and proteinic synthetic.Promote the healing time of granulation new life, shortening intractable ulcer.And syngnathus and mud eel powder also is a composite powder, and it has removing dampness, absorbing toxin and the effect of granulation promoting removing the necrotic tissue, can help the granulation growth, quickens granulation promoting and holds back mouth.Borneolum Syntheticum has that ulcer is rancid, the hot and suffocating fire-toxin that looses, sterilization, antipruritic pain, effect that dirt eliminating is smelly.Sodium benzoate has antibacterial, anti-corrosion function.Aminoacid in phenytoin Sodium and the pear powder layer is collaborative, and it is synthetic to promote fibrocyte to finish collagen fiber.Vitamin C has sterilization, bacteriostasis.
In a word, above-mentioned all components matching have the comprehensive effect of heat-clearing and toxic substances removing, removing the necrotic tissue and promoting granulation, dispersing swelling and dissipating binds, sterilization, antibacterial, absorbing toxin, the growth of promotion granulation and wound healing.
The present invention mainly is that compositions such as utilization natural amino acid and various trace elements are made, multiple effects such as its collection nutrition, sterilization, antibacterial, convergence, microcirculation improvement, and helping wound matrigel fibril synthesizes with proteinic, the speed of accelerating wound healing.So its good effect can make healing speed accelerate, and is without any side effects, can avoid wound face to infect effectively again, and, the generation of drug resistance and allergic phenomena can not caused.Average cure rate to mucocutaneous intractable, chronic ulcer reaches 98.7%.Simultaneously, it also has workable, is convenient to the characteristics of applying in medical institutions at different levels.
The specific embodiment
Describe the specific embodiment of the present invention in detail below in conjunction with embodiment.
Embodiment 1:
The present invention forms by following prescription uniform mixing.
Pear powder layer 18%; Syngnathus and mud eel powder 38%; Powdery Borax 2%; Powdery Borneolum Syntheticum 2.35%; Radix Notoginseng powder 9.0%; Powdery phenytoin Sodium 30%; Powdery sodium benzoate 0.15%; Powdery vitamin C 0.5%.
Described pear powder layer is formed by southern pearl powder 1 part (parts by weight) and 4 parts of (parts by weight) uniform mixing of Margarita layer powder, and southern pearl powder and Margarita layer powder are all on sale on market, easily purchase.Described syngnathus and mud eel powder is by 1 part of Endoconcha Sepiae (parts by weight), and Os Draconis 1 part (parts by weight) and 1 part of (parts by weight) uniform mixing of Monopteri albi dry powder form.Except that Monopteri albi dry powder is from powder process, all the other two kinds all on sale on market, easily purchases.
Embodiment 2:
The present invention forms by following prescription uniform mixing.
Pear powder layer 32%; Syngnathus and mud eel powder 40%, powdery Borax 10%; Powdery Borneolum Syntheticum 2.0%; Radix Notoginseng powder 1.3%; Powdery phenytoin Sodium 10.68%; Powdery sodium benzoate 0.02%; Powdery vitamin C 2.0%.Other are with embodiment 1.
Embodiment 3:
The present invention forms by following prescription uniform mixing.
Pear powder layer 36%; Syngnathus and mud eel powder 30%; Powdery Borax 10%; Powdery Borneolum Syntheticum 1.5%; Radix Notoginseng powder 3.3%; Powdery phenytoin Sodium 14%; Powdery sodium benzoate 0.2%; Powdery vitamin C 5%.Other are with embodiment 1.
Embodiment 4:
The present invention forms by following prescription uniform mixing.
Pear powder layer 50%; Syngnathus and mud eel powder 10%; Powdery Borax 8%; Powdery Borneolum Syntheticum 3.0%; Radix Notoginseng powder 6.7%; Powdery phenytoin Sodium 21%; Powdery sodium benzoate 0.3%; Powdery vitamin C 1.0%.Other are with embodiment 1.
Embodiment 5:
The present invention forms by following prescription uniform mixing.
Pear powder layer 45%; Syngnathus and mud eel powder 31%; Powdery Borax 9.5%; Powdery Borneolum Syntheticum 3.0%; Radix Notoginseng powder 2.3%; Powdery phenytoin Sodium 6.0%; Powdery sodium benzoate 0.2%; Powdery vitamin C 3.0%.Other are with embodiment 1.
Embodiment 6:
The present invention forms by following prescription uniform mixing.
Pear powder layer 39%; Syngnathus and mud eel powder 33%; Powdery Borax 9.0%; Powdery Borneolum Syntheticum 2.0%; Radix Notoginseng powder 4.3%; Powdery phenytoin Sodium 8.5%; Powdery sodium benzoate 0.2%; Powdery vitamin C 4.0%.Other are with embodiment 1.
Embodiment 7:
Pear powder layer 40%; Syngnathus and mud eel powder 20%; Powdery Borax 15%; Powdery Borneolum Syntheticum 1.0%; Radix Notoginseng powder 3.75%; Powdery phenytoin Sodium 17%; Powdery sodium benzoate 0.25%; Powdery vitamin C 3.0%.Other are with embodiment 1.
The test example:
1, clinical observation on the therapeutic effect
Adopt the present invention to carry out observation of curative effect case 618 examples in clinical practice, these cases all are after treating with conventional antibiotic and the routine method of changing dressings, the long-term disunion person of wound.In the long-term efficacy of these cases is observed, remove for some reason as reasons termination therapist 22 exceptions such as death, financial difficulties actual observation case 596 examples.Wherein, chronic traumatic ulcer 414 examples are all cured; Tissue necrosis 2 examples of festering after the chemotherapeutics extravasation are all cured; Decubital ulcer 59 examples are not cured 2 examples, and cure rate is 96.61%; Eczema 48 examples are all cured; Diabetic foot 20 examples are not cured 1 example, and cure rate is 95%; Blood stasis postoperative infection 30 examples are all cured; Furuncle and phyma diabrosis 9 examples are all cured; Cancer postoperative wound disunion 14 examples are all cured.Average cure rate reaches 98.7%.In the case of these observations, the shortest person of the course of disease 13 days, elder reaches 32 years.And in treatment clinical course, the course of treatment, the shortest person such as eczematosis patient can cure in 2 days, and other sick kinds 7 days the shortest courses of treatment of patient reach 46 days most.
2, model case for example
(1) patient, man, 58 years old, case number: 001.This patient in July, 92 is because of suffering from postoperative rectal cancer, intravenous drip chemotherapeutics vincristine, be seeped into outward and scratch side 9 * 4cm ulcer surface on the left wrist, the wound stench, secretions is many, tendon exposed, purple is to pink darkly outside to inside certainly for edge of wound, and thumb swells and ache, limitation of activity, conventional therapy did not have improvement in 8 months, adopted powder treatment of the present invention 46 days, wound healing, thumb is swollen to disappear, and movable function recovers.
(2), the patient, man, 65 years old, case number: 106, residual about 4 * 2cm chronic ulcer after the left leg wound does not heal through 3 years wound surface of conventional dressing change, adopt the present invention to treat 4 times, the next day once, wound surface is significantly dry, granulation is fresh, the surrounding skin pinkiness, show blood for good, skin begins to the centre growth, and 5 (next day once) healings fully continue to change dressings.
(3), the patient, man, 85 years old, case number: 392, because of the back long-term bed of fracturing, left heel rear portion decubital ulcer, fail to heal through 10 months conventional therapies, go to a doctor wound 4 * 3cm on October 20th, 2000, reach 1.5cm deeply, local skin is canescence, sclerosis, periphery is blue, the wound exudate moderate adopts the present invention to treat 38 days, fully healing.
(4), the patient, man, 66 years old.Case number: 046, because of carbon monoxide poisoning is plant man's shape several months, because large and small fecal incontinence forms perineal position eczema, companion's edema of scrotum adopts the present invention's treatment, change dressings 2 times, once-a-day, i.e. recovery from illness.
(5), the patient, man, 40 years old, case number: 405.Right side cheek furuncle and phyma squeeze broken after, fester and connect with the oral cavity.Successively treated 13 days with conventional method at hospital surgery and private clinic, nothing alleviates, and goes to a doctor, and checks: top, cheek corners of the mouth place, right side lump 4 * 4 * 3cm, and the right side facial swelling, there are 3 place's ulceration wounds the lump center, is perforation with the oral cavity, difficulty in opening mouth.Adopt drainage treatment of the present invention 9 times, the next day once, wound surface heals fully.
Claims (1)
1, a kind of powder for the treatment of intractable ulcer consists of pear powder layer, syngnathus and mud eel powder, Borax, Borneolum Syntheticum, Radix Notoginseng powder, sodium benzoate, phenytoin Sodium and vitamin C are calculated pear powder layer 18-50% by mass percentage in this powder, syngnathus and mud eel powder 10-40%, Borax 2-15%, Borneolum Syntheticum 1-5%, Radix Notoginseng powder 1.3-9%, sodium benzoate 0.02-0.3%, phenytoin Sodium 5-30%, vitamin C 0.5-5%, described pear powder layer is made up of southern pearl powder and Margarita layer powder, its proportioning is calculated as 1: 4 by weight, described syngnathus and mud eel powder is by Endoconcha Sepiae, and Os Draconis and Monopteri albi dry powder are formed, and its proportioning is calculated as 1: 1: 1 by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011405104A CN1199666C (en) | 2001-09-17 | 2001-09-17 | Medicine 'Suyusan' for treating intractable ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011405104A CN1199666C (en) | 2001-09-17 | 2001-09-17 | Medicine 'Suyusan' for treating intractable ulcer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1342491A CN1342491A (en) | 2002-04-03 |
| CN1199666C true CN1199666C (en) | 2005-05-04 |
Family
ID=4675922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011405104A Expired - Fee Related CN1199666C (en) | 2001-09-17 | 2001-09-17 | Medicine 'Suyusan' for treating intractable ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1199666C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080145454A1 (en) | 2006-12-15 | 2008-06-19 | Sirius Products, Inc. | Compositions to alleviate herpes virus symptoms |
| US8673373B2 (en) | 2006-12-15 | 2014-03-18 | Paradigm, Inc. | Homeopathic formulations for treatment of herpes virus symptoms |
| US8772324B2 (en) * | 2009-03-25 | 2014-07-08 | Keshav Malshe | Composition and methods for the treatment of wounds |
| WO2014055338A1 (en) * | 2012-10-02 | 2014-04-10 | North Texas Medical Center | Decubitus treatment system |
-
2001
- 2001-09-17 CN CNB011405104A patent/CN1199666C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1342491A (en) | 2002-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1679745A (en) | External-applied medicine for treating burn, valnus and local tumor inflammation | |
| CN108159024B (en) | Sustained-release patch for treating oral ulcer and preparation method thereof | |
| JP2010533174A (en) | Antibacterial composition | |
| CN1199666C (en) | Medicine 'Suyusan' for treating intractable ulcer | |
| CN1317017C (en) | Externally applied medicine for treating skin ulcer | |
| CN1314420C (en) | Stomatocace powder | |
| CN101152290B (en) | Externally used powder preparation stypticum | |
| CN1079257C (en) | Powder medicine for treating born and scald | |
| CN103690903A (en) | Compound traditional Chinese medicine preparation for treating trauma diseases such as burn, scald, bedsore and the like | |
| CN1068785C (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
| CN1259087C (en) | Medicine for treating trauma and sores and its preparing process | |
| CN101049353A (en) | Lotion of medication for treating dermatophytosis | |
| CN1876085A (en) | A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof | |
| CN1911231A (en) | Medicine for treating burns | |
| CN101647952A (en) | Flesh engendering and wound closing medicament for external use | |
| CN101028365A (en) | Medicine for treating burn and ambustion and its production | |
| Koenig et al. | Healing wounds with honey | |
| CN1167430C (en) | Broad-spectrum antibacterial Huangru Ointment for treating deep burn | |
| CN1408382A (en) | Medicine for curing bed sore and ulcer | |
| CN1297292C (en) | Burn treating medicine | |
| CN1843375A (en) | Traditional Chinese medicine for treating lower limb ulcer | |
| CN1616059A (en) | Medicinal composition for treating burn and scald and preparing method | |
| CN1236798C (en) | External medicine for treating bone tuberculosis | |
| RU2463971C1 (en) | Complex method of treating trophic and sluggish wounds with application of immersion autodermoplasty and chitosan-based wound covering | |
| CN1291704C (en) | Plaster design for post-operation incision |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |